Compounds > 4-iodophenoxyacetic acid
Page last updated: 2024-09-23

4-iodophenoxyacetic acid

Description

4-iodophenoxyacetic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74658
CHEMBL ID366651
SCHEMBL ID2113374
MeSH IDM0528937

Synonyms (33)

Synonym
EN300-17493
BB 0221136
OPREA1_327553
OPREA1_031755
4-iodophenoxyacetic acid, 95%
p-iodophenoxyacetic acid
4-iodophenoxyacetic acid
1878-94-0
I0644
AG-690/13155018
2-(4-iodophenoxy)acetic acid
(4-iodophenoxy)acetic acid
CHEMBL366651
inchi=1/c8h7io3/c9-6-1-3-7(4-2-6)12-5-8(10)11/h1-4h,5h2,(h,10,11)
rkorkxfkxyyhaq-uhfffaoysa-
AKOS001042351
STL164358
(p-iodophenoxy)acetic acid
einecs 217-531-0
FT-0618802
(4-iodo-phenoxy)acetic acid
(4-iodo-phenoxy)-acetic acid
SCHEMBL2113374
AC-10148
W-107760
BS-5021
acetic acid, (4-iodophenoxy)-
DTXSID80172092
mfcd00014359
Z56943814
4-iodo phenoxyacetic acid
acetic acid, 2-(4-iodophenoxy)-
SY049560

Bioassays (6)

Assay IDTitleYearJournalArticle
AID22013Solubility ratio ([HbS+drug (20 mM)]/[HbS-drug]1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
AID22012Solubility ratio ([HbS+drug (10 mM)]/[HbS-drug])1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
AID21145Solubility of Haemoglobin S (HbS) concentration after addition of acid and dithionite1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
AID22148Solubility ratio ([HbS+drug (40 mM)]/[HbS-drug])1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
AID21143Solubility of Deoxyhemoglobin S (dHbS) concentration after addition dithionite as control1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
AID22149Solubility ratio ([HbS+drug (5 mM)]/[HbS-drug])1984Journal of medicinal chemistry, Aug, Volume: 27, Issue:8
Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
2,4-dichlorophenoxyacetic acid[no description available]medium20chlorophenoxyacetic acid;
dichlorobenzene		agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
clofibric acid[no description available]medium10aromatic ether;
monocarboxylic acid;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
antineoplastic agent;
herbicide;
marine xenobiotic metabolite;
PPARalpha agonist
gemfibrozil[no description available]medium10aromatic etherantilipemic drug
phenylalanine[no description available]medium10amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
(4-tert-Butyl-phenoxy)-acetic acid[no description available]medium10monocarboxylic acid
phenoxyacetic acid[no description available]medium10aromatic ether;
monocarboxylic acid		allergen;
Aspergillus metabolite;
human xenobiotic metabolite;
plant growth retardant
4-chlorophenoxyacetic acid[no description available]medium10chlorophenoxyacetic acid;
monochlorobenzenes		phenoxy herbicide
bezafibrate[no description available]medium10aromatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
((4-bromobenzyl)oxy)acetic acid[no description available]medium10
iodine[no description available]medium20diatomic iodinenutrient
ConditionIndicatedRelationship StrengthStudiesTrials